1
|
Jin J, Fan Z, Long Y, Li Y, He Q, Yang Y, Zhong W, Lin D, Lian D, Wang X, Xiao J, Chen Y. Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel. Phytomedicine 2024; 122:155165. [PMID: 37922791 DOI: 10.1016/j.phymed.2023.155165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Revised: 09/30/2023] [Accepted: 10/24/2023] [Indexed: 11/07/2023]
Abstract
BACKGROUND Cervical cancer, which is a significant public health concern in women, currently lacks effective therapeutic drugs. Matrine, a constituent of the traditional Chinese herb Sophora flavescentis Radix, is known for its anti-cervical cancer properties and ability to induce programmed cell death. The induction of cancer cell ferroptosis, which is a novel cell death pattern, can become an effective clinical therapy for tumor in the future. However, the effect of matrine on ferroptosis in cervical cancer remains to be elucidated. PURPOSE In this study, we investigated whether matrine induces ferroptosis in cervical cancer and elucidated the underlying mechanisms. METHODS We established an SiHa-derived tumor-bearing mouse model using CB17 severe combined immunodeficient (SCID) mice and administered a group of matrine (25, 50, and 75 mg/kg) and cisplatin (2 mg/kg). We meticulously tracked alterations in body weight and tumor size and evaluated liver and kidney health using haematoxylin and eosin (H&E) staining. Using Gene Expression Omnibus (GEO) Dataset (GSE201309), we evaluated the relationship between the effects of matrine on malignant tumor cells and ferroptosis. In vitro, tetrazolium-based colorimetric (MTT), lactate dehydrogenase (LDH) and colony formation assays were used to study the effects of matrine on SiHa cell activity and cytotoxicity. We assessed ferroptosis-related protein abundance using western blotting and ferroptosis-related indices in cells using confocal immunofluorescence microscopy. The interaction of matrine with a protein linked to ferroptosis was studied using cellular thermal shift assay (CETSA). The effects of matrine on Piezo1 expression were investigated using calcium imaging. We also used Piezo1-specific siRNA to explore the role of Piezo1 in ferroptosis. RESULTS Matrine administration effectively inhibited tumor growth in a SiHa-derived tumor-bearing mouse model without inducing noticeable harm. The analysis results of GEO data set show matrine-induced effects in tumor cells were indeed involved in the process of ferroptosis. Treatment with matrine resulted in a significant reduction in GPX4 protein levels and a concurrent increase in lipid peroxide and Fe2+ content, suggesting matrine-induced modulation of ferroptosis. Matrine promoted SiHa cell death in vitro, as evidenced by the results of MTT and LDH assays. Cell death coincides with increases in intracellular Fe2+, reactive oxygen species (ROS), and lipid peroxides. Our study also revealed significant upregulation of Piezo1 expression through the action of matrine, whereas transferrin receptor (Tfr) and System Xc- (xCT) expression and interaction remained unaffected. We provided further evidence that matrine induces calcium influx through the Piezo1 channel, thereby potentially influencing ferroptosis. Transfection with Piezo1 siRNA reversed the effects of matrine in SiHa cell. CONCLUSIONS Our findings indicate that matrine exerts a protective effect against cervical cancer by inducing ferroptosis through the activation of Piezo1, but not xCT or Tfr.
Collapse
Affiliation(s)
- Jiaqi Jin
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China; Department of Gynaecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111Da De Road, Guangzhou 510120, China
| | - Zhaofeng Fan
- Department of Gynaecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111Da De Road, Guangzhou 510120, China; The Second Clinical College of Guangzhou University of Chinese Medicine, No.232 Waihuan Dong Rd,Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Yonglin Long
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China; Department of Gynaecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111Da De Road, Guangzhou 510120, China
| | - Yinping Li
- Laboratory Animal Center, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Qian He
- Laboratory Animal Center, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Yiming Yang
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Weijian Zhong
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Disheng Lin
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China
| | - Dawei Lian
- Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan 523808, China
| | - Xiao Wang
- Laboratory Animal Center, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China.
| | - Jing Xiao
- Department of Gynaecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111Da De Road, Guangzhou 510120, China.
| | - Yang Chen
- Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, No. 232 Waihuan Dong Rd., Guangzhou University Town, Panyu District, Guangzhou 510000, China.
| |
Collapse
|